{"entity":{"type":"insider","cik":"0001768722","url":"/insider/0001768722","json_url":"/insider/0001768722.json","name":"Ricardo Alonso","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2019-06-25","last":"2020-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Ricardo Alonso","source":"filing","n_filings":6,"first_seen":"2019-06-25","last_seen":"2020-03-18"}],"transactions":[{"id":2806197,"accession":"0001104659-20-035492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-035492","line_url":"/filing/0001104659-20-035492#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2288.0,"shares_display":"2,288","price_per_share":44.25,"price_display":"44.25","price_state":"stated","total_value":101244.0,"total_display":"101,244.00","total_whole":"101,244","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-18","scope":"insider"},{"id":3170996,"accession":"0001104659-20-005636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-005636","line_url":"/filing/0001104659-20-005636#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":47.02,"price_display":"47.02","price_state":"stated","total_value":107440.7,"total_display":"107,440.70","total_whole":"107,441","shares_owned_after":2288.0,"shares_owned_after_display":"2,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-17","filed_date":"2020-01-21","scope":"insider"},{"id":8116193,"accession":"0001104659-19-073912","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-073912","line_url":"/filing/0001104659-19-073912#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":47.0759,"price_display":"47.08","price_state":"stated","total_value":107568.4315,"total_display":"107,568.43","total_whole":"107,568","shares_owned_after":4573.0,"shares_owned_after_display":"4,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-18","scope":"insider"},{"id":7860832,"accession":"0001104659-19-054742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-054742","line_url":"/filing/0001104659-19-054742#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":46.7,"price_display":"46.70","price_state":"stated","total_value":106709.5,"total_display":"106,709.50","total_whole":"106,710","shares_owned_after":6858.0,"shares_owned_after_display":"6,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-17","filed_date":"2019-10-17","scope":"insider"},{"id":8281560,"accession":"0001104659-19-047563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047563","line_url":"/filing/0001104659-19-047563#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2285.0,"shares_display":"2,285","price_per_share":27.8949,"price_display":"27.89","price_state":"stated","total_value":63739.8465,"total_display":"63,739.85","total_whole":"63,740","shares_owned_after":9143.0,"shares_owned_after_display":"9,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-27","scope":"insider"},{"id":8510373,"accession":"0001104659-19-037410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-037410","line_url":"/filing/0001104659-19-037410#line-1","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001768722","owner_name":"Ricardo Alonso","owner_display_name":"Ricardo Alonso","owner_url":"/insider/0001768722","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":23.7248,"price_display":"23.72","price_state":"stated","total_value":67781.7536,"total_display":"67,781.75","total_whole":"67,782","shares_owned_after":11428.0,"shares_owned_after_display":"11,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-21","filed_date":"2019-06-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Officer","n_filings":6,"first_seen":"2019-06-25","last_seen":"2020-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001768722","retrieved_at":"2026-08-23T07:33:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}